drugset / Trial / NCT00577356
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out what effects, good and bad, the combination of docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer before removal the prostate (prostatectomy).
Timeline
- Start
- 2008-02
- Primary completion
- 2008-09
- Completion
- 2008-09
Outcome
Outcome not reported
Stopped: “Safety reasons, though no safety issues arose.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CG1940/CG8711 | Vaccine | — | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |